Melanoma is a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.

Melanoma in situ is not thought to be caused by sun exposure and can also be confused with other medical issues, which is why it’s important to consult with a dermatologist if you notice anything unusual.

A unique treatment, with a surprising ingredient, is increasing the chances of survival for some melanoma patients.

A recent study from Cleveland Clinic found genetics may play a bigger role than originally thought when it comes to melanoma.

Even though statistics show fair-skinned people are more likely to develop skin cancer, darker-skinned people are more likely to die from it.

A new Cleveland Clinic study shows that melanoma isn't just caused by environmental factors. Researchers discovered genetics can also play a role.

May 2 is known as Melanoma Monday -- the day dermatologists want to bring awareness to this deadly disease.

Good bacteria aid in digestion but there are harmful bacteria that have the potential to make us sick.

With the calendar hitting May and summer quickly approaching, that means sales of sunscreen will be ratcheting up with beach weather hitting its peak season.

Researchers are now testing a new therapy for patients with advanced melanoma that has been tough to treat.

Overall cases of melanoma increased from 2001 to 2015, the study said, especially among people 40 and older. Researchers analyzed data from nearly 1 million cases of invasive melanoma for the study, published Wednesday in the medical journal JAMA Dermatology. Melanoma is the fifth most common cancer in the United States, and linked to more than 9,000 deaths a year in the United States, the study said. The study said young adult women appeared to have twice the risk of melanoma as young adult men. Despite the rising number of melanoma cases overall, there are positives, the study noted, including new therapies over the last several years that have improved survival outcomes for patients with spreading melanoma.